TipRanks
Daewoong Pharmaceutical Co., Ltd. (KR:069620)
:069620
South Korea Market
069620
Daewoong Pharmaceutical Co., Ltd.
RESEARCH TOOLSreports

Daewoong Pharmaceutical Co., Ltd. (069620) Ratios

― Followers

Daewoong Pharmaceutical Co., Ltd. Ratios

KR:069620's free cash flow for Q2 2026 was ₩0.54. For the 2026 fiscal year, KR:069620's free cash flow was decreased by ₩ and operating cash flow was ₩0.15. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.89 1.24 0.97 0.92 1.16
Quick Ratio
 0.52 0.72 0.57 0.53 0.72
Cash Ratio
 0.18 0.29 0.16 0.18 0.22
Solvency Ratio
 0.19 0.20 0.07 0.19 0.10
Operating Cash Flow Ratio
 0.19 0.25 0.08 0.22 0.25
Short-Term Operating Cash Flow Coverage
 0.31 0.54 0.16 0.34 0.51
Net Current Asset Value
₩ -585.36B₩ -495.79B₩ -437.20B₩ -283.21B₩ -273.15B
Leverage Ratios
Debt-to-Assets Ratio
 0.36 0.35 0.33 0.27 0.29
Debt-to-Equity Ratio
 0.87 0.82 0.82 0.61 0.73
Debt-to-Capital Ratio
 0.47 0.45 0.45 0.38 0.42
Long-Term Debt-to-Capital Ratio
 0.27 0.35 0.29 0.08 0.25
Financial Leverage Ratio
 2.39 2.35 2.49 2.31 2.57
Debt Service Coverage Ratio
 0.47 0.85 0.24 0.39 0.36
Interest Coverage Ratio
 13.01 15.67 21.18 9.21 11.40
Debt to Market Cap
 0.73 0.41 0.44 0.35 0.25
Interest Debt Per Share
 81.10K 72.66K 57.03K 42.26K 41.12K
Net Debt to EBITDA
 3.01 2.69 4.86 2.17 4.04
Profitability Margins
Gross Profit Margin
51.59%51.74%51.60%49.96%49.91%
EBIT Margin
11.57%12.45%4.47%8.81%3.68%
EBITDA Margin
15.63%15.65%7.91%11.99%6.65%
Operating Profit Margin
11.65%12.45%10.40%8.81%7.48%
Pretax Profit Margin
10.98%12.21%3.97%8.87%2.99%
Net Profit Margin
11.95%12.47%1.74%8.85%3.30%
Continuous Operations Profit Margin
10.91%12.28%1.64%8.73%3.06%
Net Income Per EBT
108.86%102.10%43.74%99.79%110.20%
EBT Per EBIT
94.25%98.12%38.22%100.73%40.01%
Return on Assets (ROA)
7.70%8.29%1.25%6.88%2.70%
Return on Equity (ROE)
19.67%19.47%3.11%15.87%6.95%
Return on Capital Employed (ROCE)
11.35%11.02%10.98%10.59%8.78%
Return on Invested Capital (ROIC)
8.58%9.52%3.65%7.70%7.23%
Return on Tangible Assets
9.11%9.82%1.52%8.27%3.26%
Earnings Yield
15.58%9.81%1.70%9.08%2.38%
Efficiency Ratios
Receivables Turnover
 6.36 6.73 6.63 7.47 6.89
Payables Turnover
 9.09 7.14 8.29 6.81 7.69
Inventory Turnover
 2.50 2.44 2.69 2.85 3.07
Fixed Asset Turnover
 1.75 1.86 2.11 2.64 2.90
Asset Turnover
 0.64 0.66 0.72 0.78 0.82
Working Capital Turnover Ratio
 -184.91 24.76 -41.77 111.64 18.84
Cash Conversion Cycle
 163.06 152.73 146.97 123.32 124.30
Days of Sales Outstanding
 57.40 54.20 55.09 48.83 52.94
Days of Inventory Outstanding
 145.82 149.69 135.90 128.10 118.83
Days of Payables Outstanding
 40.16 51.15 44.02 53.62 47.48
Operating Cycle
 203.22 203.89 190.99 176.94 171.78
Cash Flow Ratios
Operating Cash Flow Per Share
 13.99K 12.88K 4.48K 11.91K 10.68K
Free Cash Flow Per Share
 -10.14K -3.65K -15.43K 2.33K 443.20
CapEx Per Share
 24.13K 16.53K 19.90K 9.57K 10.24K
Free Cash Flow to Operating Cash Flow
 -0.72 -0.28 -3.45 0.20 0.04
Dividend Paid and CapEx Coverage Ratio
 0.56 0.75 0.22 1.17 0.99
Capital Expenditure Coverage Ratio
 0.58 0.78 0.22 1.24 1.04
Operating Cash Flow Coverage Ratio
 0.18 0.18 0.08 0.29 0.26
Operating Cash Flow to Sales Ratio
 0.10 0.09 0.04 0.10 0.09
Free Cash Flow Yield
-9.42%-2.12%-12.21%1.99%0.28%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 6.45 10.12 58.79 11.02 42.06
Price-to-Sales (P/S) Ratio
 0.77 1.27 1.02 0.98 1.39
Price-to-Book (P/B) Ratio
 1.19 1.98 1.83 1.75 2.92
Price-to-Free Cash Flow (P/FCF) Ratio
 -10.74 -47.17 -8.19 50.29 362.14
Price-to-Operating Cash Flow Ratio
 7.83 13.38 28.24 9.86 15.03
Price-to-Earnings Growth (PEG) Ratio
 0.04 0.01 -0.74 0.06 0.59
Price-to-Fair Value
 1.19 1.98 1.83 1.75 2.92
Enterprise Value Multiple
 7.95 10.81 17.78 10.30 24.91
Enterprise Value
 2.02T 2.66T 2.00T 1.70T 2.12T
EV to EBITDA
 7.89 10.81 17.78 10.30 24.91
EV to Sales
 1.23 1.69 1.41 1.24 1.66
EV to Free Cash Flow
 -17.17 -62.77 -11.27 63.72 432.21
EV to Operating Cash Flow
 12.44 17.81 38.85 12.49 17.94
Tangible Book Value Per Share
 68.91K 66.21K 50.43K 53.82K 42.93K
Shareholders’ Equity Per Share
 91.82K 86.83K 69.06K 67.17K 54.93K
Tax and Other Ratios
Effective Tax Rate
 <0.01 >-0.01 0.59 0.02 -0.02
Revenue Per Share
 141.12K 135.57K 123.65K 120.39K 115.65K
Net Income Per Share
 16.87K 16.90K 2.15K 10.66K 3.82K
Tax Burden
 1.09 1.02 0.44 1.00 1.10
Interest Burden
 0.95 0.98 0.89 1.01 0.81
Research & Development to Revenue
 0.12 0.11 0.12 0.12 0.13
SG&A to Revenue
 0.21 0.19 0.19 0.28 0.19
Stock-Based Compensation to Revenue
 >-0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
 0.83 0.76 2.21 1.12 3.02
Currency in KRW